

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.49679246 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.98570743 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.98570743 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.94614969 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.94614969 |
| 6 | negative T cell selection (GO:0043383) | 5.44180881 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.35379836 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.31325541 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.31291662 |
| 10 | negative thymic T cell selection (GO:0045060) | 5.30928770 |
| 11 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.17167921 |
| 12 | positive thymic T cell selection (GO:0045059) | 5.06953973 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.98843650 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.98843650 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 4.98843650 |
| 16 | positive regulation by symbiont of host defense response (GO:0052509) | 4.98843650 |
| 17 | modulation by symbiont of host defense response (GO:0052031) | 4.98843650 |
| 18 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.98843650 |
| 19 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.97230637 |
| 20 | regulation of gamma-delta T cell activation (GO:0046643) | 4.71025244 |
| 21 | leukocyte aggregation (GO:0070486) | 4.38298908 |
| 22 | interferon-gamma production (GO:0032609) | 4.36442167 |
| 23 | positive T cell selection (GO:0043368) | 4.33743403 |
| 24 | thymic T cell selection (GO:0045061) | 4.33232749 |
| 25 | response to interleukin-15 (GO:0070672) | 4.32794279 |
| 26 | T cell migration (GO:0072678) | 4.32748553 |
| 27 | microglial cell activation (GO:0001774) | 4.13177106 |
| 28 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.12251521 |
| 29 | cellular response to interleukin-15 (GO:0071350) | 4.07190920 |
| 30 | detection of other organism (GO:0098543) | 4.05459536 |
| 31 | macrophage activation involved in immune response (GO:0002281) | 4.02086892 |
| 32 | positive regulation of isotype switching (GO:0045830) | 3.95108085 |
| 33 | T cell selection (GO:0045058) | 3.94977186 |
| 34 | detection of molecule of bacterial origin (GO:0032490) | 3.91433743 |
| 35 | neutrophil activation (GO:0042119) | 3.89003935 |
| 36 | cellular extravasation (GO:0045123) | 3.85313928 |
| 37 | detection of bacterium (GO:0016045) | 3.81531401 |
| 38 | regulation of B cell differentiation (GO:0045577) | 3.79757785 |
| 39 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.74231056 |
| 40 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.72608860 |
| 41 | detection of external biotic stimulus (GO:0098581) | 3.69462004 |
| 42 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.63809640 |
| 43 | positive regulation of DNA recombination (GO:0045911) | 3.63165357 |
| 44 | response to peptidoglycan (GO:0032494) | 3.62113233 |
| 45 | respiratory burst (GO:0045730) | 3.58163623 |
| 46 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.57021290 |
| 47 | activated T cell proliferation (GO:0050798) | 3.55246505 |
| 48 | T cell receptor signaling pathway (GO:0050852) | 3.49771932 |
| 49 | regulation of response to interferon-gamma (GO:0060330) | 3.49178896 |
| 50 | negative regulation of interleukin-12 production (GO:0032695) | 3.48635957 |
| 51 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.45527833 |
| 52 | T cell costimulation (GO:0031295) | 3.45075649 |
| 53 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.44980775 |
| 54 | B cell receptor signaling pathway (GO:0050853) | 3.44787865 |
| 55 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.43632233 |
| 56 | response to host immune response (GO:0052572) | 3.43632233 |
| 57 | neutrophil mediated immunity (GO:0002446) | 3.43118809 |
| 58 | lymphocyte costimulation (GO:0031294) | 3.42746113 |
| 59 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.42017244 |
| 60 | immunoglobulin mediated immune response (GO:0016064) | 3.39544228 |
| 61 | negative regulation of phagocytosis (GO:0050765) | 3.39122969 |
| 62 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.37340588 |
| 63 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.35694640 |
| 64 | megakaryocyte development (GO:0035855) | 3.35576062 |
| 65 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.35044711 |
| 66 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.34900625 |
| 67 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.34845103 |
| 68 | regulation of isotype switching (GO:0045191) | 3.32955747 |
| 69 | granulocyte activation (GO:0036230) | 3.32251668 |
| 70 | positive regulation of B cell differentiation (GO:0045579) | 3.30684301 |
| 71 | macrophage activation (GO:0042116) | 3.30366972 |
| 72 | positive regulation of B cell mediated immunity (GO:0002714) | 3.26351812 |
| 73 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.26351812 |
| 74 | myeloid cell activation involved in immune response (GO:0002275) | 3.19645514 |
| 75 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.18121606 |
| 76 | detection of biotic stimulus (GO:0009595) | 3.17554554 |
| 77 | mast cell activation (GO:0045576) | 3.15379129 |
| 78 | negative regulation of interleukin-1 production (GO:0032692) | 3.13625186 |
| 79 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.13381091 |
| 80 | positive regulation of humoral immune response (GO:0002922) | 3.11884571 |
| 81 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.10321390 |
| 82 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.10321390 |
| 83 | ribosomal small subunit assembly (GO:0000028) | 3.10002640 |
| 84 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.07217774 |
| 85 | regulation of B cell mediated immunity (GO:0002712) | 3.07208183 |
| 86 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.05741008 |
| 87 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.05741008 |
| 88 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.05406660 |
| 89 | sequestering of actin monomers (GO:0042989) | 3.04977576 |
| 90 | regulation of regulatory T cell differentiation (GO:0045589) | 3.04974909 |
| 91 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.04277124 |
| 92 | regulation of mast cell activation (GO:0033003) | 3.03691853 |
| 93 | leukocyte degranulation (GO:0043299) | 3.02059500 |
| 94 | dendritic cell migration (GO:0036336) | 3.01995934 |
| 95 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.99914731 |
| 96 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.99450302 |
| 97 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.99450302 |
| 98 | negative regulation of interleukin-6 production (GO:0032715) | 2.98131806 |
| 99 | lymph node development (GO:0048535) | 2.95085294 |
| 100 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.93359403 |
| 101 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.92627034 |
| 102 | DNA deamination (GO:0045006) | 2.92343382 |
| 103 | defense response to protozoan (GO:0042832) | 2.92282340 |
| 104 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.92050782 |
| 105 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.90242309 |
| 106 | positive regulation of mast cell activation (GO:0033005) | 2.89093754 |
| 107 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.89061662 |
| 108 | negative regulation of B cell mediated immunity (GO:0002713) | 2.89061662 |
| 109 | positive regulation of granulocyte differentiation (GO:0030854) | 2.88717349 |
| 110 | response to host (GO:0075136) | 2.87170233 |
| 111 | response to host defenses (GO:0052200) | 2.87170233 |
| 112 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.87170233 |
| 113 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.86884446 |
| 114 | T cell homeostasis (GO:0043029) | 2.86031806 |
| 115 | myeloid leukocyte mediated immunity (GO:0002444) | 2.85093549 |
| 116 | response to type I interferon (GO:0034340) | 2.84968134 |
| 117 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.84087646 |
| 118 | regulation of tolerance induction (GO:0002643) | 2.82054716 |
| 119 | cellular response to type I interferon (GO:0071357) | 2.82030225 |
| 120 | type I interferon signaling pathway (GO:0060337) | 2.82030225 |
| 121 | NIK/NF-kappaB signaling (GO:0038061) | 2.81156818 |
| 122 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.80452355 |
| 123 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.79060283 |
| 124 | leukocyte cell-cell adhesion (GO:0007159) | 2.78993637 |
| 125 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.78182397 |
| 126 | negative regulation of adaptive immune response (GO:0002820) | 2.76548993 |
| 127 | tolerance induction (GO:0002507) | 2.76498845 |
| 128 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.74603734 |
| 129 | cytidine metabolic process (GO:0046087) | 2.74453408 |
| 130 | cytidine catabolic process (GO:0006216) | 2.74453408 |
| 131 | cytidine deamination (GO:0009972) | 2.74453408 |
| 132 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.73135777 |
| 133 | negative regulation of innate immune response (GO:0045824) | 2.72784422 |
| 134 | positive regulation of antigen processing and presentation (GO:0002579) | 2.71671002 |
| 135 | positive regulation of immunoglobulin production (GO:0002639) | 2.71225779 |
| 136 | regulation of memory T cell differentiation (GO:0043380) | 2.71149398 |
| 137 | positive regulation of response to tumor cell (GO:0002836) | 2.70726069 |
| 138 | positive regulation of immune response to tumor cell (GO:0002839) | 2.70726069 |
| 139 | regulation of immune response to tumor cell (GO:0002837) | 2.70726069 |
| 140 | regulation of response to tumor cell (GO:0002834) | 2.70726069 |
| 141 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.70413591 |
| 142 | natural killer cell activation (GO:0030101) | 2.68971454 |
| 143 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.68960784 |
| 144 | pinocytosis (GO:0006907) | 2.67528569 |
| 145 | neutrophil activation involved in immune response (GO:0002283) | 2.66137824 |
| 146 | negative regulation of T cell mediated immunity (GO:0002710) | 2.63513227 |
| 147 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.63509339 |
| 148 | angiogenesis involved in wound healing (GO:0060055) | 2.61964691 |
| 149 | cellular response to exogenous dsRNA (GO:0071360) | 2.61727524 |
| 150 | lymphocyte migration (GO:0072676) | 2.61453487 |
| 151 | positive regulation of lamellipodium assembly (GO:0010592) | 2.61075461 |
| 152 | positive regulation of interleukin-2 production (GO:0032743) | 2.59240769 |
| 153 | regulation of cell killing (GO:0031341) | 2.59181326 |
| 154 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.57723255 |
| 155 | myeloid dendritic cell activation (GO:0001773) | 2.57643892 |
| 156 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.57202711 |
| 157 | actin nucleation (GO:0045010) | 2.56565760 |
| 158 | lymphocyte homeostasis (GO:0002260) | 2.53181766 |
| 159 | mast cell activation involved in immune response (GO:0002279) | 2.52801144 |
| 160 | mast cell degranulation (GO:0043303) | 2.52801144 |
| 161 | regulation of RIG-I signaling pathway (GO:0039535) | 2.52676731 |
| 162 | regulation of T cell tolerance induction (GO:0002664) | 2.52059230 |
| 163 | response to protozoan (GO:0001562) | 2.51982083 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.15078981 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.80284303 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.77259042 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.69857074 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.07141886 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.93103814 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.88438837 |
| 8 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.77922603 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.71906251 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.71842307 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.71770643 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.70874180 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.69098123 |
| 14 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.67193519 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.58946334 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.46670735 |
| 17 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.45648837 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.43271844 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.41371600 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 2.39436770 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.29767607 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.28735033 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.24807846 |
| 24 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.07735547 |
| 25 | MYB_26560356_Chip-Seq_TH1_Human | 2.06526369 |
| 26 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.05526544 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 2.02111548 |
| 28 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.01713170 |
| 29 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.97529507 |
| 30 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.94856850 |
| 31 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93441873 |
| 32 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.90815959 |
| 33 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.90273645 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.88302403 |
| 35 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.87378724 |
| 36 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.86614291 |
| 37 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86544730 |
| 38 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86194623 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.85721150 |
| 40 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.84847494 |
| 41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80600471 |
| 42 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.77819077 |
| 43 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.77791178 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77450688 |
| 45 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.75852422 |
| 46 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.73047602 |
| 47 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.72546731 |
| 48 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.69182016 |
| 49 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.68414211 |
| 50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.68164374 |
| 51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.63463887 |
| 52 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.61511790 |
| 53 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.60075901 |
| 54 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.59874327 |
| 55 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58188055 |
| 56 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.56834224 |
| 57 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.55514286 |
| 58 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.55437817 |
| 59 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.52969273 |
| 60 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.48311460 |
| 61 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.46559492 |
| 62 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.45793163 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.45402074 |
| 64 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.44876314 |
| 65 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.44385735 |
| 66 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44339756 |
| 67 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.42258823 |
| 68 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41984656 |
| 69 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.40727566 |
| 70 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.40372207 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40369908 |
| 72 | MAF_26560356_Chip-Seq_TH2_Human | 1.39001626 |
| 73 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.35773220 |
| 74 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.34994192 |
| 75 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33382105 |
| 76 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.32517921 |
| 77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.32330878 |
| 78 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.28779829 |
| 79 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28229792 |
| 80 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.25624875 |
| 81 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.24401002 |
| 82 | SPI1_23127762_ChIP-Seq_K562_Human | 1.22902820 |
| 83 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22695159 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.22103127 |
| 85 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.20791128 |
| 86 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.19416656 |
| 87 | GATA3_26560356_Chip-Seq_TH2_Human | 1.17457239 |
| 88 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.17381936 |
| 89 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15874375 |
| 90 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.14780506 |
| 91 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.13733748 |
| 92 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.12753904 |
| 93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12265741 |
| 94 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.11236687 |
| 95 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.11021877 |
| 96 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.10108539 |
| 97 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08807223 |
| 98 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.08719902 |
| 99 | VDR_22108803_ChIP-Seq_LS180_Human | 1.08384511 |
| 100 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.08283677 |
| 101 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.06493246 |
| 102 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05795464 |
| 103 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.05608614 |
| 104 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04601048 |
| 105 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03590706 |
| 106 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.03588842 |
| 107 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.03480496 |
| 108 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.02912123 |
| 109 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.02733941 |
| 110 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.02657553 |
| 111 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.02187355 |
| 112 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.01527176 |
| 113 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.00880892 |
| 114 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.00491965 |
| 115 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00475065 |
| 116 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00436701 |
| 117 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99324376 |
| 118 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.98915769 |
| 119 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98876257 |
| 120 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.98333374 |
| 121 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97951186 |
| 122 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97073032 |
| 123 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.96401667 |
| 124 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95727473 |
| 125 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.95479047 |
| 126 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.94864428 |
| 127 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.94762669 |
| 128 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94093918 |
| 129 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93821637 |
| 130 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.93779875 |
| 131 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.91234015 |
| 132 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.89861946 |
| 133 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.89690136 |
| 134 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.89499619 |
| 135 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.89396269 |
| 136 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.89396269 |
| 137 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.89207956 |
| 138 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88932288 |
| 139 | AR_20517297_ChIP-Seq_VCAP_Human | 0.88921911 |
| 140 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.88023827 |
| 141 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87520099 |
| 142 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86632627 |
| 143 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.85308874 |
| 144 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84656242 |
| 145 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.84614827 |
| 146 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84368771 |
| 147 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.84151661 |
| 148 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.83718433 |
| 149 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.83327023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 3.83383049 |
| 2 | MP0005671_abnormal_response_to | 3.80306391 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.77217247 |
| 4 | MP0000685_abnormal_immune_system | 3.27117572 |
| 5 | MP0009785_altered_susceptibility_to | 3.11964966 |
| 6 | MP0001800_abnormal_humoral_immune | 2.88979131 |
| 7 | MP0002396_abnormal_hematopoietic_system | 2.67105204 |
| 8 | MP0005387_immune_system_phenotype | 2.64977496 |
| 9 | MP0001790_abnormal_immune_system | 2.64977496 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.61677211 |
| 11 | MP0005025_abnormal_response_to | 2.52647127 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.52492096 |
| 13 | MP0002398_abnormal_bone_marrow | 2.51967785 |
| 14 | MP0003436_decreased_susceptibility_to | 2.51583125 |
| 15 | MP0001819_abnormal_immune_cell | 2.50179903 |
| 16 | MP0002723_abnormal_immune_serum | 2.50147780 |
| 17 | MP0009333_abnormal_splenocyte_physiolog | 2.41996343 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.40351108 |
| 19 | MP0002405_respiratory_system_inflammati | 2.24912591 |
| 20 | MP0003724_increased_susceptibility_to | 2.22168364 |
| 21 | MP0000716_abnormal_immune_system | 2.20028757 |
| 22 | MP0002419_abnormal_innate_immunity | 2.14394308 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.13834446 |
| 24 | MP0000689_abnormal_spleen_morphology | 2.11453733 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.09242695 |
| 26 | MP0002722_abnormal_immune_system | 2.06949493 |
| 27 | MP0004147_increased_porphyrin_level | 1.97707034 |
| 28 | MP0002429_abnormal_blood_cell | 1.93164868 |
| 29 | MP0006082_CNS_inflammation | 1.92569426 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.90712266 |
| 31 | MP0002132_abnormal_respiratory_system | 1.89806799 |
| 32 | MP0002277_abnormal_respiratory_mucosa | 1.83897089 |
| 33 | MP0001873_stomach_inflammation | 1.83391761 |
| 34 | MP0005360_urolithiasis | 1.82324253 |
| 35 | MP0003656_abnormal_erythrocyte_physiolo | 1.81708178 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.81687894 |
| 37 | MP0000703_abnormal_thymus_morphology | 1.79244145 |
| 38 | MP0001853_heart_inflammation | 1.78013132 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.77406124 |
| 40 | MP0005397_hematopoietic_system_phenotyp | 1.61770549 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.61770549 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.60561940 |
| 43 | MP0003806_abnormal_nucleotide_metabolis | 1.60294252 |
| 44 | MP0004947_skin_inflammation | 1.57460403 |
| 45 | MP0005075_abnormal_melanosome_morpholog | 1.55938043 |
| 46 | MP0003866_abnormal_defecation | 1.55339348 |
| 47 | MP0003195_calcinosis | 1.51476223 |
| 48 | MP0008469_abnormal_protein_level | 1.51204824 |
| 49 | MP0004808_abnormal_hematopoietic_stem | 1.50857951 |
| 50 | MP0000569_abnormal_digit_pigmentation | 1.49816345 |
| 51 | MP0009840_abnormal_foam_cell | 1.47862567 |
| 52 | MP0004381_abnormal_hair_follicle | 1.42764816 |
| 53 | MP0004883_abnormal_blood_vessel | 1.42036159 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.37703570 |
| 55 | MP0002006_tumorigenesis | 1.34426685 |
| 56 | MP0000858_altered_metastatic_potential | 1.31623028 |
| 57 | MP0002876_abnormal_thyroid_physiology | 1.30981588 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.29230290 |
| 59 | MP0000490_abnormal_crypts_of | 1.26890480 |
| 60 | MP0005365_abnormal_bile_salt | 1.24522028 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.24104791 |
| 62 | MP0004510_myositis | 1.17550222 |
| 63 | MP0002138_abnormal_hepatobiliary_system | 1.16912091 |
| 64 | MP0003252_abnormal_bile_duct | 1.16257633 |
| 65 | MP0001533_abnormal_skeleton_physiology | 1.16141901 |
| 66 | MP0002928_abnormal_bile_duct | 1.14714141 |
| 67 | MP0005310_abnormal_salivary_gland | 1.14473287 |
| 68 | MP0002933_joint_inflammation | 1.13911500 |
| 69 | MP0003011_delayed_dark_adaptation | 1.11372098 |
| 70 | MP0005058_abnormal_lysosome_morphology | 1.10616101 |
| 71 | MP0005084_abnormal_gallbladder_morpholo | 1.09276387 |
| 72 | MP0004142_abnormal_muscle_tone | 1.05357139 |
| 73 | MP0003300_gastrointestinal_ulcer | 1.05266345 |
| 74 | MP0002019_abnormal_tumor_incidence | 1.03629951 |
| 75 | MP0000609_abnormal_liver_physiology | 1.01738859 |
| 76 | MP0003787_abnormal_imprinting | 1.01390723 |
| 77 | MP0001764_abnormal_homeostasis | 1.01324585 |
| 78 | MP0002139_abnormal_hepatobiliary_system | 1.00409089 |
| 79 | MP0003646_muscle_fatigue | 0.99033649 |
| 80 | MP0003693_abnormal_embryo_hatching | 0.98859587 |
| 81 | MP0003045_fibrosis | 0.97694018 |
| 82 | MP0005164_abnormal_response_to | 0.97308831 |
| 83 | MP0009764_decreased_sensitivity_to | 0.96980929 |
| 84 | MP0003303_peritoneal_inflammation | 0.96431398 |
| 85 | MP0002653_abnormal_ependyma_morphology | 0.91411857 |
| 86 | MP0006054_spinal_hemorrhage | 0.90509658 |
| 87 | MP0009763_increased_sensitivity_to | 0.88372148 |
| 88 | MP0001986_abnormal_taste_sensitivity | 0.88211047 |
| 89 | MP0004484_altered_response_of | 0.87252123 |
| 90 | MP0003075_altered_response_to | 0.87045576 |
| 91 | MP0008877_abnormal_DNA_methylation | 0.86968914 |
| 92 | MP0001851_eye_inflammation | 0.86716128 |
| 93 | MP0005319_abnormal_enzyme/_coenzyme | 0.83554200 |
| 94 | MP0001501_abnormal_sleep_pattern | 0.83311162 |
| 95 | MP0002909_abnormal_adrenal_gland | 0.82488571 |
| 96 | MP0001663_abnormal_digestive_system | 0.82487008 |
| 97 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82204743 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.81845249 |
| 99 | MP0008872_abnormal_physiological_respon | 0.81198262 |
| 100 | MP0003828_pulmonary_edema | 0.80513948 |
| 101 | MP0009643_abnormal_urine_homeostasis | 0.80127492 |
| 102 | MP0005085_abnormal_gallbladder_physiolo | 0.78804514 |
| 103 | MP0006036_abnormal_mitochondrial_physio | 0.78375969 |
| 104 | MP0008057_abnormal_DNA_replication | 0.76836572 |
| 105 | MP0008007_abnormal_cellular_replicative | 0.75175541 |
| 106 | MP0000015_abnormal_ear_pigmentation | 0.75009779 |
| 107 | MP0005451_abnormal_body_composition | 0.74164796 |
| 108 | MP0000343_altered_response_to | 0.74002154 |
| 109 | MP0003943_abnormal_hepatobiliary_system | 0.73168811 |
| 110 | MP0004043_abnormal_pH_regulation | 0.73099257 |
| 111 | MP0010329_abnormal_lipoprotein_level | 0.72768553 |
| 112 | MP0000598_abnormal_liver_morphology | 0.72688919 |
| 113 | MP0004130_abnormal_muscle_cell | 0.71076710 |
| 114 | MP0005166_decreased_susceptibility_to | 0.70587794 |
| 115 | MP0003448_altered_tumor_morphology | 0.70296537 |
| 116 | MP0003878_abnormal_ear_physiology | 0.68819546 |
| 117 | MP0005377_hearing/vestibular/ear_phenot | 0.68819546 |
| 118 | MP0005376_homeostasis/metabolism_phenot | 0.68568500 |
| 119 | MP0002095_abnormal_skin_pigmentation | 0.68334396 |
| 120 | MP0008875_abnormal_xenobiotic_pharmacok | 0.67122164 |
| 121 | MP0003077_abnormal_cell_cycle | 0.66358393 |
| 122 | MP0002136_abnormal_kidney_physiology | 0.66277633 |
| 123 | MP0009278_abnormal_bone_marrow | 0.65678781 |
| 124 | MP0003186_abnormal_redox_activity | 0.65253048 |
| 125 | MP0002332_abnormal_exercise_endurance | 0.65166010 |
| 126 | MP0001666_abnormal_nutrient_absorption | 0.64621141 |
| 127 | MP0005023_abnormal_wound_healing | 0.62731784 |
| 128 | MP0005174_abnormal_tail_pigmentation | 0.61770637 |
| 129 | MP0008260_abnormal_autophagy | 0.60241294 |
| 130 | MP0002693_abnormal_pancreas_physiology | 0.59898778 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 4.77312019 |
| 2 | Abnormality of T cell number (HP:0011839) | 4.58959723 |
| 3 | IgM deficiency (HP:0002850) | 4.51912600 |
| 4 | Panhypogammaglobulinemia (HP:0003139) | 4.32921864 |
| 5 | Abnormality of T cells (HP:0002843) | 4.16605394 |
| 6 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.13908755 |
| 7 | Recurrent fungal infections (HP:0002841) | 3.96642216 |
| 8 | Recurrent bronchitis (HP:0002837) | 3.94458785 |
| 9 | Recurrent viral infections (HP:0004429) | 3.89900603 |
| 10 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.89045877 |
| 11 | Recurrent cutaneous fungal infections (HP:0011370) | 3.89045877 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.87464751 |
| 13 | Severe combined immunodeficiency (HP:0004430) | 3.87207515 |
| 14 | Eczematoid dermatitis (HP:0000976) | 3.85672953 |
| 15 | Recurrent abscess formation (HP:0002722) | 3.69030713 |
| 16 | Agammaglobulinemia (HP:0004432) | 3.66630421 |
| 17 | Myositis (HP:0100614) | 3.64682368 |
| 18 | Combined immunodeficiency (HP:0005387) | 3.61319218 |
| 19 | Pustule (HP:0200039) | 3.61052413 |
| 20 | Chronic otitis media (HP:0000389) | 3.57981959 |
| 21 | Hypochromic microcytic anemia (HP:0004840) | 3.41929172 |
| 22 | Abnormality of T cell physiology (HP:0011840) | 3.40781781 |
| 23 | Nasal polyposis (HP:0100582) | 3.38992440 |
| 24 | Meningitis (HP:0001287) | 3.20978108 |
| 25 | IgG deficiency (HP:0004315) | 3.16824308 |
| 26 | Encephalitis (HP:0002383) | 3.09583033 |
| 27 | Thrombocytosis (HP:0001894) | 3.07081747 |
| 28 | Recurrent bacterial skin infections (HP:0005406) | 3.05793230 |
| 29 | Recurrent skin infections (HP:0001581) | 3.02852547 |
| 30 | Abnormality of the nasal mucosa (HP:0000433) | 2.98968580 |
| 31 | Inflammation of the large intestine (HP:0002037) | 2.97954714 |
| 32 | Thyroiditis (HP:0100646) | 2.96913255 |
| 33 | Gastrointestinal inflammation (HP:0004386) | 2.93198138 |
| 34 | Hypoplasia of the thymus (HP:0000778) | 2.91616494 |
| 35 | Petechiae (HP:0000967) | 2.90768160 |
| 36 | Episodic fever (HP:0001954) | 2.90126114 |
| 37 | Colitis (HP:0002583) | 2.88348328 |
| 38 | Hypochromic anemia (HP:0001931) | 2.78172263 |
| 39 | Epistaxis (HP:0000421) | 2.70831600 |
| 40 | Abnormality of macrophages (HP:0004311) | 2.69455511 |
| 41 | Vasculitis (HP:0002633) | 2.68427707 |
| 42 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.64701183 |
| 43 | Abnormality of eosinophils (HP:0001879) | 2.64223770 |
| 44 | Lymphopenia (HP:0001888) | 2.61032840 |
| 45 | Abnormality of B cell number (HP:0010975) | 2.56347281 |
| 46 | B lymphocytopenia (HP:0010976) | 2.56347281 |
| 47 | Chest pain (HP:0100749) | 2.55909171 |
| 48 | Urticaria (HP:0001025) | 2.54499312 |
| 49 | Prolonged bleeding time (HP:0003010) | 2.54298626 |
| 50 | Mediastinal lymphadenopathy (HP:0100721) | 2.46722415 |
| 51 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.44765294 |
| 52 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.44707151 |
| 53 | Chronic diarrhea (HP:0002028) | 2.44575214 |
| 54 | Abnormality of the pleura (HP:0002103) | 2.39857111 |
| 55 | Stomatitis (HP:0010280) | 2.39279221 |
| 56 | Impaired platelet aggregation (HP:0003540) | 2.38911667 |
| 57 | Abnormal platelet function (HP:0011869) | 2.38911667 |
| 58 | Acute hepatic failure (HP:0006554) | 2.38607463 |
| 59 | Orchitis (HP:0100796) | 2.37957061 |
| 60 | Stomach cancer (HP:0012126) | 2.37381484 |
| 61 | Joint swelling (HP:0001386) | 2.36854947 |
| 62 | Retrobulbar optic neuritis (HP:0100654) | 2.35395903 |
| 63 | Optic neuritis (HP:0100653) | 2.35395903 |
| 64 | Leukocytosis (HP:0001974) | 2.35320403 |
| 65 | Recurrent sinusitis (HP:0011108) | 2.35101179 |
| 66 | Lymphoma (HP:0002665) | 2.35058499 |
| 67 | Pulmonary infiltrates (HP:0002113) | 2.34495355 |
| 68 | Autoimmune thrombocytopenia (HP:0001973) | 2.33284722 |
| 69 | Reduced antithrombin III activity (HP:0001976) | 2.32829695 |
| 70 | Hemoptysis (HP:0002105) | 2.32308310 |
| 71 | Type 2 muscle fiber atrophy (HP:0003554) | 2.31531576 |
| 72 | Obstructive lung disease (HP:0006536) | 2.31413963 |
| 73 | Chronic obstructive pulmonary disease (HP:0006510) | 2.31413963 |
| 74 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.30416624 |
| 75 | Bronchitis (HP:0012387) | 2.28426992 |
| 76 | Gingivitis (HP:0000230) | 2.27033928 |
| 77 | Gastrointestinal infarctions (HP:0005244) | 2.26081276 |
| 78 | Neutropenia (HP:0001875) | 2.25309124 |
| 79 | Congenital stationary night blindness (HP:0007642) | 2.24630125 |
| 80 | Verrucae (HP:0200043) | 2.22873923 |
| 81 | Papilloma (HP:0012740) | 2.22873923 |
| 82 | Pancreatic cysts (HP:0001737) | 2.22078155 |
| 83 | Muscle fiber atrophy (HP:0100295) | 2.21302948 |
| 84 | Microcytic anemia (HP:0001935) | 2.19491430 |
| 85 | Arterial thrombosis (HP:0004420) | 2.19125147 |
| 86 | Spontaneous hematomas (HP:0007420) | 2.18569161 |
| 87 | Gingival bleeding (HP:0000225) | 2.15998974 |
| 88 | Keratoconjunctivitis sicca (HP:0001097) | 2.15590084 |
| 89 | Type I transferrin isoform profile (HP:0003642) | 2.13195933 |
| 90 | Vacuolated lymphocytes (HP:0001922) | 2.11849541 |
| 91 | Abnormality of the prostate (HP:0008775) | 2.10553090 |
| 92 | Chronic sinusitis (HP:0011109) | 2.10458119 |
| 93 | Granulocytopenia (HP:0001913) | 2.09252884 |
| 94 | Gastrointestinal stroma tumor (HP:0100723) | 2.07584002 |
| 95 | Gangrene (HP:0100758) | 2.07482635 |
| 96 | Eosinophilia (HP:0001880) | 2.04654494 |
| 97 | Ragged-red muscle fibers (HP:0003200) | 2.04395037 |
| 98 | Skin rash (HP:0000988) | 2.02772131 |
| 99 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.02617736 |
| 100 | Poikilocytosis (HP:0004447) | 2.02338206 |
| 101 | Pulmonary embolism (HP:0002204) | 2.01880989 |
| 102 | Keratitis (HP:0000491) | 2.01359785 |
| 103 | Acne (HP:0001061) | 2.00934922 |
| 104 | Absent/shortened dynein arms (HP:0200106) | 2.00140343 |
| 105 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.00140343 |
| 106 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98627611 |
| 107 | Peritonitis (HP:0002586) | 1.98021009 |
| 108 | Periodontitis (HP:0000704) | 1.97869333 |
| 109 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.94728986 |
| 110 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.94728986 |
| 111 | Anorexia (HP:0002039) | 1.94507921 |
| 112 | Increased IgM level (HP:0003496) | 1.94251062 |
| 113 | Keratoconjunctivitis (HP:0001096) | 1.93260114 |
| 114 | Abnormal platelet volume (HP:0011876) | 1.93122583 |
| 115 | Albinism (HP:0001022) | 1.91646209 |
| 116 | Increased IgE level (HP:0003212) | 1.90690582 |
| 117 | Cellulitis (HP:0100658) | 1.90504823 |
| 118 | Aplastic anemia (HP:0001915) | 1.90493518 |
| 119 | Increased serum ferritin (HP:0003281) | 1.89577396 |
| 120 | Skin ulcer (HP:0200042) | 1.89487192 |
| 121 | Cheilitis (HP:0100825) | 1.88295609 |
| 122 | Abnormality of iron homeostasis (HP:0011031) | 1.87489612 |
| 123 | Vertigo (HP:0002321) | 1.86516174 |
| 124 | Polyneuropathy (HP:0001271) | 1.82205950 |
| 125 | Alveolar cell carcinoma (HP:0006519) | 1.78623234 |
| 126 | Attenuation of retinal blood vessels (HP:0007843) | 1.78387625 |
| 127 | Autoimmune hemolytic anemia (HP:0001890) | 1.75931452 |
| 128 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.75761443 |
| 129 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.75761443 |
| 130 | Abnormality of glycolipid metabolism (HP:0010969) | 1.75761443 |
| 131 | Abnormality of the pericardium (HP:0001697) | 1.73763811 |
| 132 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.72594561 |
| 133 | Hypothermia (HP:0002045) | 1.71734282 |
| 134 | Osteomyelitis (HP:0002754) | 1.71574805 |
| 135 | Amyloidosis (HP:0011034) | 1.71330019 |
| 136 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.71193491 |
| 137 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.71193491 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.30052613 |
| 2 | TXK | 3.95549161 |
| 3 | FRK | 3.23813743 |
| 4 | ITK | 2.89617506 |
| 5 | ZAP70 | 2.79808362 |
| 6 | TYK2 | 2.68696951 |
| 7 | IKBKE | 2.46496292 |
| 8 | IRAK4 | 2.41824133 |
| 9 | FLT3 | 2.40585739 |
| 10 | JAK3 | 2.39245104 |
| 11 | GRK6 | 2.36581425 |
| 12 | TEC | 2.34812635 |
| 13 | TAOK3 | 2.20642852 |
| 14 | KIT | 2.13495522 |
| 15 | TBK1 | 2.11956791 |
| 16 | BTK | 1.95045942 |
| 17 | FGFR4 | 1.90503473 |
| 18 | MAP3K14 | 1.88162251 |
| 19 | JAK1 | 1.84831162 |
| 20 | KDR | 1.84532992 |
| 21 | SYK | 1.81810538 |
| 22 | STK10 | 1.76432163 |
| 23 | BLK | 1.72157693 |
| 24 | PKN2 | 1.69326819 |
| 25 | IKBKB | 1.54071081 |
| 26 | CSF1R | 1.50995492 |
| 27 | MAP3K12 | 1.47255746 |
| 28 | LCK | 1.47116865 |
| 29 | EPHB1 | 1.46015705 |
| 30 | IRAK1 | 1.41288775 |
| 31 | NME2 | 1.36077530 |
| 32 | MAP3K2 | 1.32163985 |
| 33 | MST4 | 1.26218002 |
| 34 | CSK | 1.25934007 |
| 35 | MAP2K3 | 1.21557271 |
| 36 | NEK9 | 1.21252775 |
| 37 | HCK | 1.16683186 |
| 38 | CAMKK2 | 1.14124858 |
| 39 | TLK1 | 1.12984007 |
| 40 | MAP4K2 | 1.12927925 |
| 41 | OXSR1 | 1.12592079 |
| 42 | FGR | 1.12568818 |
| 43 | NLK | 1.12304142 |
| 44 | PIM1 | 1.09577045 |
| 45 | GRK1 | 1.06828202 |
| 46 | DAPK2 | 1.06735403 |
| 47 | MAPK11 | 1.05508928 |
| 48 | WNK3 | 1.04462034 |
| 49 | PIK3CG | 1.03792976 |
| 50 | PIM2 | 1.03626201 |
| 51 | TGFBR1 | 1.02959164 |
| 52 | PINK1 | 1.02362587 |
| 53 | LRRK2 | 0.99805711 |
| 54 | ERN1 | 0.99727380 |
| 55 | IRAK3 | 0.99528920 |
| 56 | INSRR | 0.98383979 |
| 57 | MAPK13 | 0.97828682 |
| 58 | LYN | 0.97692789 |
| 59 | TGFBR2 | 0.95985561 |
| 60 | ACVR1B | 0.94851322 |
| 61 | TESK2 | 0.93390548 |
| 62 | TAOK1 | 0.93217090 |
| 63 | FGFR3 | 0.91279369 |
| 64 | MAP3K13 | 0.91212526 |
| 65 | YES1 | 0.89844799 |
| 66 | PAK3 | 0.89082461 |
| 67 | PRKCQ | 0.88820726 |
| 68 | PTK2B | 0.88106753 |
| 69 | STK24 | 0.87454391 |
| 70 | JAK2 | 0.87271739 |
| 71 | MAP3K10 | 0.86507836 |
| 72 | MAP2K4 | 0.82674138 |
| 73 | EEF2K | 0.81073287 |
| 74 | TSSK6 | 0.80971122 |
| 75 | TRPM7 | 0.79566924 |
| 76 | MYLK | 0.79408773 |
| 77 | IRAK2 | 0.78638060 |
| 78 | EPHA3 | 0.78557978 |
| 79 | MAP3K1 | 0.76959003 |
| 80 | SIK3 | 0.76945518 |
| 81 | ADRBK1 | 0.75375376 |
| 82 | MAP2K6 | 0.74979536 |
| 83 | ADRBK2 | 0.73861247 |
| 84 | FES | 0.71930538 |
| 85 | BMPR2 | 0.70728854 |
| 86 | STK16 | 0.68774261 |
| 87 | PRKD2 | 0.68715288 |
| 88 | CLK1 | 0.67625532 |
| 89 | MATK | 0.66901314 |
| 90 | PDK1 | 0.66737160 |
| 91 | PASK | 0.65293323 |
| 92 | CHUK | 0.64026946 |
| 93 | TNK2 | 0.63281812 |
| 94 | STK11 | 0.63022464 |
| 95 | RAF1 | 0.63004148 |
| 96 | GRK7 | 0.61770115 |
| 97 | MAP3K7 | 0.61446299 |
| 98 | MAP3K3 | 0.60891589 |
| 99 | KSR2 | 0.59684967 |
| 100 | RIPK4 | 0.59500104 |
| 101 | MAP3K6 | 0.54613170 |
| 102 | RPS6KA6 | 0.54432676 |
| 103 | STK4 | 0.54401537 |
| 104 | BCKDK | 0.53527114 |
| 105 | EIF2AK1 | 0.52023732 |
| 106 | RPS6KA4 | 0.51805828 |
| 107 | MAPK12 | 0.50468145 |
| 108 | ZAK | 0.49406437 |
| 109 | CDK4 | 0.47892709 |
| 110 | SCYL2 | 0.45292556 |
| 111 | CDK8 | 0.45230427 |
| 112 | HIPK2 | 0.44965047 |
| 113 | STK38 | 0.44358551 |
| 114 | CAMK4 | 0.43806078 |
| 115 | EIF2AK3 | 0.43099503 |
| 116 | PTK6 | 0.42868689 |
| 117 | RPS6KB2 | 0.42812098 |
| 118 | RPS6KL1 | 0.42282019 |
| 119 | RPS6KC1 | 0.42282019 |
| 120 | PRKCH | 0.41247077 |
| 121 | MAP3K5 | 0.40766444 |
| 122 | PRKCD | 0.40182808 |
| 123 | FYN | 0.39893260 |
| 124 | ABL1 | 0.39687815 |
| 125 | MAPK7 | 0.38809710 |
| 126 | MAP3K11 | 0.37628965 |
| 127 | PRKCZ | 0.37030983 |
| 128 | MARK2 | 0.36465943 |
| 129 | TRIB3 | 0.35875766 |
| 130 | PRKAA2 | 0.35687135 |
| 131 | DAPK1 | 0.34763833 |
| 132 | TIE1 | 0.33957698 |
| 133 | MAP2K2 | 0.32725010 |
| 134 | NUAK1 | 0.32364245 |
| 135 | CAMKK1 | 0.32287030 |
| 136 | MARK3 | 0.31823870 |
| 137 | FER | 0.31545418 |
| 138 | MAPKAPK2 | 0.31364760 |
| 139 | ILK | 0.30858447 |
| 140 | BMPR1B | 0.30801812 |
| 141 | CDC42BPA | 0.29828116 |
| 142 | MAPK3 | 0.29824890 |
| 143 | MAPK4 | 0.29449697 |
| 144 | TAOK2 | 0.27509916 |
| 145 | NEK2 | 0.26488238 |
| 146 | SIK2 | 0.24623969 |
| 147 | MAPKAPK3 | 0.24595969 |
| 148 | BUB1 | 0.24527208 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.16052541 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.67443346 |
| 3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.66832405 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.65998803 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.41121375 |
| 6 | Measles_Homo sapiens_hsa05162 | 2.37192871 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.34395261 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.22672012 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.18854386 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.07232447 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.01207235 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.95522802 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 1.95178677 |
| 14 | Asthma_Homo sapiens_hsa05310 | 1.89788231 |
| 15 | Proteasome_Homo sapiens_hsa03050 | 1.85361590 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.81532922 |
| 17 | Base excision repair_Homo sapiens_hsa03410 | 1.73552932 |
| 18 | DNA replication_Homo sapiens_hsa03030 | 1.71216326 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.60762724 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.60142947 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.52549770 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.44713014 |
| 23 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.44652127 |
| 24 | Ribosome_Homo sapiens_hsa03010 | 1.35168542 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.29514912 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.29488548 |
| 27 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.28753974 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.28268769 |
| 29 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.26795495 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.25383999 |
| 31 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.24327039 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.24243330 |
| 33 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.22146791 |
| 34 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.17177981 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.16874727 |
| 36 | Mismatch repair_Homo sapiens_hsa03430 | 1.15602904 |
| 37 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.12064838 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.10036752 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.09424628 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.08821709 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.08559850 |
| 42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.08130373 |
| 43 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.06451645 |
| 44 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.05194117 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.03626221 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.03184642 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 1.03157458 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.03140814 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.02683230 |
| 50 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.00071706 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 0.97929432 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 0.97524901 |
| 53 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.95724588 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.94743768 |
| 55 | RNA polymerase_Homo sapiens_hsa03020 | 0.94348532 |
| 56 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.94073795 |
| 57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.92634427 |
| 58 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.92611134 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91680656 |
| 60 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.90656774 |
| 61 | Hepatitis B_Homo sapiens_hsa05161 | 0.90099592 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90093860 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.89526447 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88831639 |
| 65 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.86212582 |
| 66 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.84884896 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.83070555 |
| 68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.82978175 |
| 69 | Homologous recombination_Homo sapiens_hsa03440 | 0.82643571 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.82116598 |
| 71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.81712876 |
| 72 | ABC transporters_Homo sapiens_hsa02010 | 0.81553726 |
| 73 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.81267167 |
| 74 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.81104097 |
| 75 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.77319965 |
| 76 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.76036549 |
| 77 | Malaria_Homo sapiens_hsa05144 | 0.75028251 |
| 78 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.74836554 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74681935 |
| 80 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.72868424 |
| 81 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.71341730 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71191388 |
| 83 | Lysosome_Homo sapiens_hsa04142 | 0.71020486 |
| 84 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.70325015 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.69942483 |
| 86 | Tuberculosis_Homo sapiens_hsa05152 | 0.69915807 |
| 87 | Phototransduction_Homo sapiens_hsa04744 | 0.69140079 |
| 88 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.68901356 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66781052 |
| 90 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.66769573 |
| 91 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66304922 |
| 92 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.66020319 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.65670709 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | 0.65385873 |
| 95 | Protein export_Homo sapiens_hsa03060 | 0.65319243 |
| 96 | Platelet activation_Homo sapiens_hsa04611 | 0.63025206 |
| 97 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.62432939 |
| 98 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60329777 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59435261 |
| 100 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.58301873 |
| 101 | Peroxisome_Homo sapiens_hsa04146 | 0.57962054 |
| 102 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57624817 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.57606350 |
| 104 | Pertussis_Homo sapiens_hsa05133 | 0.55756587 |
| 105 | Carbon metabolism_Homo sapiens_hsa01200 | 0.53113399 |
| 106 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52665654 |
| 107 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.52189601 |
| 108 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51173808 |
| 109 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.51142134 |
| 110 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.49439857 |
| 111 | Spliceosome_Homo sapiens_hsa03040 | 0.49251980 |
| 112 | RNA degradation_Homo sapiens_hsa03018 | 0.48552121 |
| 113 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48348442 |
| 114 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47566661 |
| 115 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.47449996 |
| 116 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.46809334 |
| 117 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45391257 |
| 118 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.44560328 |
| 119 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.44364724 |
| 120 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.43876003 |
| 121 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43545579 |
| 122 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.42946767 |
| 123 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42534925 |
| 124 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.42450282 |
| 125 | Retinol metabolism_Homo sapiens_hsa00830 | 0.42081818 |
| 126 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.40752594 |
| 127 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.40729051 |
| 128 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39747261 |
| 129 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39147002 |
| 130 | Parkinsons disease_Homo sapiens_hsa05012 | 0.39142150 |
| 131 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.39104625 |
| 132 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38947918 |
| 133 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.38947689 |
| 134 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.37969561 |
| 135 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34608387 |
| 136 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34414920 |
| 137 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34293320 |
| 138 | Insulin resistance_Homo sapiens_hsa04931 | 0.32919301 |
| 139 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.31804586 |
| 140 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30188677 |
| 141 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.29012899 |
| 142 | Mineral absorption_Homo sapiens_hsa04978 | 0.28530841 |

